Originally published byEU-Startups
CurifyLabs, a Helsinki-based HealthTech company transforming how personalised medicines are made, today announced the closing of a €12 million ($14 million) Series A round to expand U.S. operations, strengthen supply chain infrastructure, enhance customer support, and accelerate product innovation. The round was co-led by Sandwater and HealthCap, with participation from Tesi (Finnish Industry Investment Ltd.) […]
The post Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
From Kickoff To First Concept: How To Turn Brand Strategy Into Visual Direction
17h ago
Slothful summer app lets you scroll simply by tilting your head
10h ago
Destructive Windows backdoor stuffs multiple wipers and ransomware code into a single package
13h ago
LisaFPGA brings Apple's magnificent misfire back in programmable logic
13h ago
New Lithuanian unicorn: Oxylabs ends bootstrapped streak after securing €113.6 million at €3.1 billion valuation
1d ago